Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
24.74 USD | +8.01% | -0.38% | -17.89% |
05-10 | UBS Cuts Price Target on Arrowhead Pharmaceuticals to $71 From $75, Keeps Buy Rating | MT |
05-09 | Arrowhead Pharmaceuticals Swings to Loss in Fiscal Q2 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.89% | 2.85B | |
+7.00% | 111B | |
+10.52% | 106B | |
-12.42% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-9.99% | 16.81B | |
+38.75% | 12.54B | |
-24.80% | 8.09B |
- Stock Market
- Equities
- ARWR Stock
- News Arrowhead Pharmaceuticals, Inc.
- Piper Sandler Adjusts Arrowhead Pharmaceuticals' Price Target to $52 From $55, Maintains Overweight Rating